Hemoglobin meter market seen topping $4.7B by 2030

The global hemoglobin meter market is forecast to rise from $2.75 billion in 2025 to $4.74 billion by 2030, driven by anemia screening, home diagnostics and wider point-of-care testing. North America led the market in 2025 as portable and handheld devices gain traction across hospitals, primary care and remote settings.

Why it matters: - The hemoglobin meter market is tied directly to anemia detection and blood health monitoring, which affect treatment decisions across clinics, hospitals and home care. - Faster, more portable testing can expand access in rural and remote communities where laboratory testing is harder to reach. - Rising demand for home-use and point-of-care devices points to a broader shift toward decentralized diagnostics.

What happened: - The Business Research Company released its Hemoglobin Meter Market Report 2026 on August 10, 2026. - The report says the market will grow from $2.75 billion in 2025 to $3.07 billion in 2026. - The report projects the market will reach $4.74 billion by 2030. - North America held the largest share of the hemoglobin meter market in 2025.

The details: - Hemoglobin meters measure hemoglobin in blood and help monitor anemia and overall blood health. - Some devices are designed for home use, letting individuals check hemoglobin levels independently. - Growth in the historical period was driven by rising anemia prevalence, more hospital diagnostic testing, continued reliance on laboratory hemoglobin assessments, higher awareness of blood health monitoring and expanded clinical laboratory infrastructure. - Forecast growth is linked to home healthcare diagnostics, wider acceptance of portable and handheld meters, expanded anemia screening, improved sensor accuracy and broader point-of-care testing. - The report highlights trends including more home-use devices, stronger demand for rapid point-of-care tests, earlier anemia detection, ongoing monitoring, more testing in primary care and more user-friendly handheld meters. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables. - The report offers a free sample here. - The full report is available here.

Between the lines: - The market outlook reflects a shift from centralized lab testing toward faster screening in primary care, homes and underserved regions. - The report frames anemia prevalence as the main demand driver, which suggests screening needs remain the core commercial opportunity. - IHME data cited in the release show nearly 2 billion people worldwide live with anemia, with higher prevalence among women than men. - The same data show 31.2% of women and 17.5% of men are affected globally, while among ages 15–49 the rates are 33.7% for women and 11.3% for men.

What's next: - The hemoglobin meter market is expected to keep growing as screening expands and handheld devices improve. - Wider adoption of point-of-care testing in rural and remote communities could become a key growth path through 2030. - The report signals continued demand for devices that combine speed, accuracy and ease of use.

The bottom line: - Hemoglobin meters are moving from a niche diagnostic tool to a broader screening category as anemia burden, home care and portable testing all climb.